Drug intelligence / Profile preview

Articure

Development stage
Phase 4
Lead developer
Amneal Pharmaceuticals
Modality
Small Molecules
Administration
Intramuscular
01

Overview

Articure is a fixed-dose combination intramuscular injection containing diclofenac sodium (75 mg) and lidocaine hydrochloride (20 mg), developed by Global Pharmaceuticals. It is indicated for the short-term management of acute moderate to severe pain and inflammatory conditions, including osteoarthritis, rheumatoid arthritis, acute gout, low back pain, and postoperative pain. Diclofenac sodium is a potent nonsteroidal anti-inflammatory drug (NSAID) that reduces pain and swelling by inhibiting cyclooxygenase enzymes and subsequent prostaglandin synthesis. Lidocaine hydrochloride is a local anesthetic that blocks voltage-gated sodium channels to prevent nerve depolarization and action potential propagation, which specifically helps to alleviate injection-site discomfort associated with intramuscular diclofenac administration.

Brand names
Articure
Other names
Diclofenac Sodium 75mg + Lidocaine HCl 20mgDiclofenac Sodium 75mg + Lidocaine Hydrochloride 20mgdiclofenac + lidocainediclofenac + lignocaine
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)SCN10A (Sodium channel protein type X alpha subunit)SCN11A (NaV1.9)SCN9A (Sodium channel protein type 9 subunit alpha)

Beyond the preview

Go deeper on Articure.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Articure.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call